Viral Genetics, Inc. (VRAL) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Viral Genetics, Inc. Company Snapshot

Business Description:

Viral Genetics, Inc. operates in the Pharmaceutical preparations sector. Viral Genetics, Inc. is a biotechnology company researching new treatments and methods of detection for human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS), Lyme disease, staph and strep, cancer and certain other autoimmune and infectious diseases. It has two approaches, which form the basis of its research includes targeted peptides therapies (TPT) and metabolic disruption technology (MDT). TPTs are custom-designed protein fragment, which work to modify certain immune system reactions. MDT encompasses a way to change how some types of cells use fat and sugar/carbohydrates for energy. In our complete report available for purchase the company is compared to: Northwest Biotherapeutics, Inc., Immunobiotics, Incorporation and Vitro Diagnostics, Inc..

Viral Genetics, Inc.

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): .01
(Figures in U.S. Dollars)

1 Week	3.6%	13 Weeks	-32.6%

4 Weeks	11.5%	52 Weeks	-65.9%

Viral Genetics, Inc. Key Data:

Ticker:	VRAL	Country:	UNITED STATES

Exchanges:	OTC	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	5,677 (Year Ending Jan 2011).	Employees:	2

Currency:	U.S. Dollars	Market Cap:	10,865,373

Fiscal Yr Ends:	December	Shares Outstanding:	749,336,047

Share Type:	Common	Closely Held Shares:	193,329,513

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.